Journal of Pharmacological Sciences (Jan 2011)

Inhibitory Effects of a Tryptamine Derivative on Ultraviolet Radiation–Induced Apoptosis in MC3T3-E1 Mouse Osteoblasts

  • Yoshikazu Mikami,
  • Motoki Senoo,
  • Mio Lee,
  • Kiyoshi Yamada,
  • Kuniyasu Ochiai,
  • Masaki J. Honda,
  • Eri Watanabe,
  • Nobukazu Watanabe,
  • Masanori Somei,
  • Minoru Takagi

Journal volume & issue
Vol. 115, no. 2
pp. 214 – 220

Abstract

Read online

MS-IPA1 is a new synthetic compound that is synthesized from tryptamine. Recently, our group demonstrated that SST-VED-I-1, which has a similar chemical structure to MS-IPA1, inhibits starvation-induced apoptosis in osteoblasts. However, the effects of MS-IPA1 on apoptosis in osteoblasts have not yet been examined. Therefore, this study examined the effects of this compound on apoptosis in osteoblasts. In this study, MC3T3-E1 mouse osteoblasts were used and apoptosis was induced by ultraviolet radiation (UV). We investigated the effect of MS-IPA1 on apoptosis by analyzing caspase3/7 activity, translocation of phosphatidylserine (PS), and mRNA expression levels of Bcl-2 and Bax. In addition, it was investigated whether MS-IPA1 affects cell proliferation and cell cycle progression. We found that MS-IPA1 had no effect on cell proliferation or cell cycle progression. However, MS-IPA1 suppressed UV-induced cell death in a dose-dependent manner, which was accompanied with the inhibition of caspase activation and translocation of PS. Furthermore, after UV exposure, Bcl-2 expression was increased in the MS-IPA1–treated cells as compared to that in the vehicle-treated cells. In contrast, Bax expression was decreased in the MS-IPA1–treated cell as compared to that in the vehicle-treated cells. These results suggest that MS-IPA1 has an inhibitory effect on apoptosis in osteoblasts through a Bcl-2 family-dependent signaling pathway. Keywords:: MS-IPA1, tryptamine, apoptosis